https://matrix-fkb.no https://matrix-fkb.no/no/om-oss https://matrix-fkb.no/no/aktuelt https://matrix-fkb.no/no/forskning https://matrix-fkb.no/no/nasjonalt-klinisk-nettverk https://matrix-fkb.no/en/home https://matrix-fkb.no/no/studier https://matrix-fkb.no/en/about https://matrix-fkb.no/en/research https://matrix-fkb.no/en/clinical-network https://matrix-fkb.no/no/arkiv/nyheter https://matrix-fkb.no/no/arkiv/publikasjoner https://matrix-fkb.no/no/arkiv/studier https://matrix-fkb.no/no/arkiv/eventer https://matrix-fkb.no/no/arkiv https://matrix-fkb.no/en/news https://matrix-fkb.no/en/archive-2 https://matrix-fkb.no/en/archive/news https://matrix-fkb.no/en/archive/publications https://matrix-fkb.no/en/archive/studies https://matrix-fkb.no/en/archive/events https://matrix-fkb.no/no/kontakt https://matrix-fkb.no/en/contact https://matrix-fkb.no/en/studies https://matrix-fkb.no/no/nettstedkart https://matrix-fkb.no/en/sitemap https://matrix-fkb.no/en/npcm-symposium/home https://matrix-fkb.no/en/npcm-symposium/program https://matrix-fkb.no/en/npcm-symposium/registration https://matrix-fkb.no/en/npcm-symposium/abstract-submission https://matrix-fkb.no/en/npcm-symposium/speakers https://matrix-fkb.no/en/npcm-symposium/topics https://matrix-fkb.no/en/npcm-symposium/practical https://matrix-fkb.no/en/pcm4eu/home https://matrix-fkb.no/en/pcm4eu/project https://matrix-fkb.no/no/arkiv/nyhetsbrev https://matrix-fkb.no/en/archive/newsletters https://matrix-fkb.no/en/pcm4eu/training https://matrix-fkb.no/en/pcm4eu/partners https://matrix-fkb.no/en/pcm4eu/news https://matrix-fkb.no/en/pcm4eu/contact https://matrix-fkb.no/no/arkiv/eksterne-nyheter https://matrix-fkb.no/en/prime-rose/home https://matrix-fkb.no/en/prime-rose/project https://matrix-fkb.no/en/prime-rose/outreach https://matrix-fkb.no/en/prime-rose/partners https://matrix-fkb.no/en/prime-rose/news https://matrix-fkb.no/en/prime-rose/trials https://matrix-fkb.no/en/prime-rose/contact https://matrix-fkb.no/en/pcm4eu/clinical-trials-cross-border-access https://matrix-fkb.no/en/prime-rose/outcome https://matrix-fkb.no/no/arkiv/arsrapporter https://matrix-fkb.no/en/archive/annual-reports https://matrix-fkb.no/no/brukermedvirkning https://matrix-fkb.no/no/aktuelt/16-millioner-til-to-nye-forskningsprosjekter-i-matrix https://matrix-fkb.no/no/aktuelt/20-millioner-til-avansert-car-t-celleterapi-studie https://matrix-fkb.no/no/aktuelt/8-millioner-til-forskning-pa-persontilpasset-immunterapi-mot-brystkreft https://matrix-fkb.no/no/aktuelt/acta-oncologica-nordic-precision-cancer-medicine-symposium-2023 https://matrix-fkb.no/no/aktuelt/acta-oncologica-nordic-precision-cancer-medicine-symposium-2025 https://matrix-fkb.no/no/aktuelt/acta-oncologica-nordic-precision-cancer-medicine-symposium-2025---save-the-date https://matrix-fkb.no/no/aktuelt/alice-studien-mottar-norsk-selskap-for-immunologis-forskningspris-for-2023 https://matrix-fkb.no/no/aktuelt/apning-av-masteremnet-innforing-i-kliniske-studier-for-helsepersonell https://matrix-fkb.no/no/aktuelt/arets-kurs-i-brukermedvirkning-innen-medisinsk-og-helsefaglig-forskning-en-suksess https://matrix-fkb.no/no/aktuelt/aslaug-helland-overrakt-kong-olav-vs-kreftforskningspris https://matrix-fkb.no/no/aktuelt/aslaug-helland-valgt-inn-i-det-europeiske-vitenskapsakademiet-for-kreft https://matrix-fkb.no/no/aktuelt/aslaug-helland-valgt-inn-i-det-norske-videnskaps-akademi https://matrix-fkb.no/no/aktuelt/data-fra-alice-studien-publisert-i-nature-medicine https://matrix-fkb.no/no/aktuelt/data-fra-icon-studien-publisert-i-journal-for-immunotherapy-of-cancer https://matrix-fkb.no/no/aktuelt/dr-ragnar-morks-pris-for-fremragende-kreftforskning-2025-tildelt-sigrid-skanland https://matrix-fkb.no/no/aktuelt/en-tumormikromiljomodell-av-kronisk-lymfatisk-leukemi-muliggjor-testing-av-medikamentfolsomhet-for-veiledning-innen-presisjonsmedisin https://matrix-fkb.no/no/aktuelt/fkb-forum https://matrix-fkb.no/no/aktuelt/forskningssenter-for-klinisk-kreftbehandling-matrix-tildelt-128-millioner https://matrix-fkb.no/no/aktuelt/forste-besok-av-matrix-scientific-advisory-board https://matrix-fkb.no/no/aktuelt/fotoprosjekt-om-kreftpasienter https://matrix-fkb.no/no/aktuelt/gjesteforelesing-ved-ignacio-wistuba-translating-molecular-pathology-of-lung-cancer-to-the-clinical-practice https://matrix-fkb.no/no/aktuelt/gjesteforelesning-ved-dr-ozlem-tureci-rna-based-therapeutics-and-personalized-neoantigen-cancer-vaccines https://matrix-fkb.no/no/aktuelt/h-m-kongen-har-utnevnt-stein-kaasa-til-ridder-1-klasse-av-den-kongelige-norske-st-olavs-orden https://matrix-fkb.no/no/aktuelt/helse-forde-forsknings-og-innovasjon-i-fokus https://matrix-fkb.no/no/aktuelt/immunregulerende-signalveier-og-tumorimmununnvikelsesmekanismer https://matrix-fkb.no/no/aktuelt/innovative-palliative-care-for-people-with-cancer https://matrix-fkb.no/no/aktuelt/inspirerende-matrix-samling-i-stavanger https://matrix-fkb.no/no/aktuelt/institutt-for-kreftforskning-markerte-70-arsjubileum-under-norwegian-cancer-symposium-2024 https://matrix-fkb.no/no/aktuelt/jane2---shaping-the-eu-networks-of-expertise-on-cancer https://matrix-fkb.no/no/aktuelt/jon-amund-kyte-ny-professor-ii-ved-oslomet https://matrix-fkb.no/no/aktuelt/kathinka-schmidt-slordahl-disputerte-for-phd-graden https://matrix-fkb.no/no/aktuelt/kjetil-mottok-acta-oncologica-prisen-2024-under-onkologidagarna-i-malmo https://matrix-fkb.no/no/aktuelt/kjetil-tasken-mottar-innovasjonsprisen-ved-uio https://matrix-fkb.no/no/aktuelt/kjetil-tasken-mottar-prisen-som-fremragende-forsker-ved-oslo-universitetssykehus-for-2024 https://matrix-fkb.no/no/aktuelt/kjetil-tasken-overrakt-innovasjonsprisen-2023 https://matrix-fkb.no/no/aktuelt/kjetil-tasken-tildelt-acta-oncologica-award-av-svensk-onkologisk-forening https://matrix-fkb.no/no/aktuelt/klinbeforsk-tildeling-til-avansert-car-t-celleterapi-studie https://matrix-fkb.no/no/aktuelt/knut-smeland-ansatt-som-forsteamanuensis-ii-pa-oslomet https://matrix-fkb.no/no/aktuelt/kong-olav-vs-kreftforskningspris-2023-tildeles-aslaug-helland https://matrix-fkb.no/no/aktuelt/kurs-i-brukermedvirkning-i-medisinsk-og-helsefaglig-forskning https://matrix-fkb.no/no/aktuelt/legemiddelselskapet-beone-medicines-blir-med-i-matrix-rare-studien https://matrix-fkb.no/no/aktuelt/legemiddelselskapet-johnson-johnson-blir-med-i-impress-norway https://matrix-fkb.no/no/aktuelt/matrix-arsrapport-2022 https://matrix-fkb.no/no/aktuelt/matrix-arsrapport-2023 https://matrix-fkb.no/no/aktuelt/matrix-arsrapport-2024 https://matrix-fkb.no/no/aktuelt/matrix-brukerrad-pa-nasjonalt-kurs-om-brukermedvirkning-i-forskning https://matrix-fkb.no/no/aktuelt/matrix-drug-sensitivity-screening https://matrix-fkb.no/no/aktuelt/matrix-pa-esmo-2023 https://matrix-fkb.no/no/aktuelt/matrix-pa-esmo-2025-i-berlin https://matrix-fkb.no/no/aktuelt/matrix-pa-onkologisk-forum-2025 https://matrix-fkb.no/no/aktuelt/matrix-samling-i-stavanger https://matrix-fkb.no/no/aktuelt/matrix-scientific-advisory-board-etablert https://matrix-fkb.no/no/aktuelt/medikamentscreening-identifiserer-smamolekylaere-hemmere-av-regulatoriske-t-celler https://matrix-fkb.no/no/aktuelt/mrna-som-infeksjonsforebygging-og-kreftbehandling https://matrix-fkb.no/no/aktuelt/mypath-matrix https://matrix-fkb.no/no/aktuelt/mypath-matrix-organiserte-fokusgruppe-workshop-i-brussel https://matrix-fkb.no/no/aktuelt/mypath-matrix-representert-pa-forskningskveld-ved-sykehuset-telemark https://matrix-fkb.no/no/aktuelt/nasjonalt-mote-i-oslo-samlet-matrix-partnere https://matrix-fkb.no/no/aktuelt/nobelprisen-i-medisin-tildeles-oppdagerne-av-immuntoleranse https://matrix-fkb.no/no/aktuelt/nordic-precision-medicine-symposium https://matrix-fkb.no/no/aktuelt/novartis-er-forste-legemiddelselskap-inn-i-matrix-rare https://matrix-fkb.no/no/aktuelt/npcm2025-15-17-september https://matrix-fkb.no/no/aktuelt/nye-forskningsmidler-fra-helse-sor-ost https://matrix-fkb.no/no/aktuelt/offisiell-apning-av-horizon-eu-cancer-mission-prosjektet-prime-rose https://matrix-fkb.no/no/aktuelt/offisiell-apning-av-matrix https://matrix-fkb.no/no/aktuelt/onkologisk-forum-2024-i-bergen https://matrix-fkb.no/no/aktuelt/oppstart-av-mypath-matrix-i-forde https://matrix-fkb.no/no/aktuelt/oxford-nanopore-og-matrix-samarbeider-for-a-fremme-forskning-innen-presisjonsonkologi https://matrix-fkb.no/no/aktuelt/pcm4u-personalised-cancer-medicine-for-all-eu-citizens https://matrix-fkb.no/no/aktuelt/pioneering-palliative-care https://matrix-fkb.no/no/aktuelt/prime-rose-et-europeisk-nettverk-for-kliniske-studier-innen-presisjonsonkologi-og-et-implementeringsinitiativ-finansiert-av-eus-cancer-mission https://matrix-fkb.no/no/aktuelt/prosjektet-chronos-mottar-5-millioner-fra-nfr-til-kommersialisering-av-ny-teknologi https://matrix-fkb.no/no/aktuelt/prosjektet-cll-outcome-far-finansiering-via-eu-programmet-european-partnership-for-personalised-medicine https://matrix-fkb.no/no/aktuelt/prosjektet-matrix-rare-mottar-9-millioner-til-persontilpasset-behandling-av-pasienter-med-sjeldne-kreftformer https://matrix-fkb.no/no/aktuelt/publikasjon-i-nature-reviews-drug-discovery https://matrix-fkb.no/no/aktuelt/publikasjon-i-science https://matrix-fkb.no/no/aktuelt/seminar-om-offentlig-tjenesteinnovasjon---hold-av-datoen https://matrix-fkb.no/no/aktuelt/sigrid-skanland-karet-til-arets-forsker-2023 https://matrix-fkb.no/no/aktuelt/sigrid-skanland-lanserer-fotoboken-mennesker-med-kreft https://matrix-fkb.no/no/aktuelt/spennende-program-klart-for-nordic-precision-cancer-medicine-symposium-15-17-september https://matrix-fkb.no/no/aktuelt/stort-engasjement-pa-symposium-for-offentlig-tjenesteinnovasjon https://matrix-fkb.no/no/aktuelt/the-norwegian-cancer-symposium-2024 https://matrix-fkb.no/sykehus/akershus-universitetssykehus https://matrix-fkb.no/sykehus/alesund-sjukehus https://matrix-fkb.no/sykehus/haukeland-universitetssykehus https://matrix-fkb.no/sykehus/helse-fonna https://matrix-fkb.no/sykehus/helse-forde https://matrix-fkb.no/sykehus/nordlandssykehuset https://matrix-fkb.no/sykehus/oslo-universitetssykehus https://matrix-fkb.no/sykehus/sorlandet-sykehus https://matrix-fkb.no/sykehus/st-olavs-universitetssykehus https://matrix-fkb.no/sykehus/stavanger-universitetssykehus https://matrix-fkb.no/sykehus/sykehuset-i-levanger https://matrix-fkb.no/sykehus/sykehuset-i-ostfold https://matrix-fkb.no/sykehus/sykehuset-i-telemark https://matrix-fkb.no/sykehus/sykehuset-i-vestfold https://matrix-fkb.no/sykehus/sykehuset-innlandet https://matrix-fkb.no/sykehus/universitetssykehus-nord-norge-hf https://matrix-fkb.no/hospitals/akershus-university-hospital https://matrix-fkb.no/hospitals/alesund-hospital https://matrix-fkb.no/hospitals/forde-hospital https://matrix-fkb.no/hospitals/haugesund-hospital https://matrix-fkb.no/hospitals/haukeland-university-hospital https://matrix-fkb.no/hospitals/innlandet-hospital https://matrix-fkb.no/hospitals/levanger-hospital https://matrix-fkb.no/hospitals/nordland-hospital https://matrix-fkb.no/hospitals/oslo-university-hospital https://matrix-fkb.no/hospitals/ostfold-hospital https://matrix-fkb.no/hospitals/sorlandet-hospital https://matrix-fkb.no/hospitals/st-olavs-hospital https://matrix-fkb.no/hospitals/stavanger-university-hospital https://matrix-fkb.no/hospitals/telemark-hospital https://matrix-fkb.no/hospitals/university-hospital-north-norway https://matrix-fkb.no/hospitals/vestfold-hospital https://matrix-fkb.no/en/news/a-tumor-microenvironment-model-of-chronic-lymphocytic-leukemia-enables-drug-sensitivity-testing-to-guide-precision-medicine https://matrix-fkb.no/en/news/acta-oncologica-nordic-precision-cancer-medicine-symposium-2023 https://matrix-fkb.no/en/news/advanced-car-t-cell-therapy-study-receives-20-million-nok https://matrix-fkb.no/en/news/aslaug-helland-elected-as-a-member-of-the-norwegian-academy-of-science-and-letters https://matrix-fkb.no/en/news/aslaug-helland-presented-king-olav-vs-cancer-research-prize https://matrix-fkb.no/en/news/aslaug-helland-receives-king-olav-vs-prize-for-cancer-research-2023 https://matrix-fkb.no/en/news/data-from-the-alice-trial-published-in-nature-medicine https://matrix-fkb.no/en/news/distinguished-guest-lecture-by-dr-ozlem-tureci-rna-based-therapeutics-and-personalized-neoantigen-cancer-vaccines https://matrix-fkb.no/en/news/dr-ragnar-morks-prize-for-excellent-cancer-research-2025-awarded-to-sigrid-skanland https://matrix-fkb.no/en/news/drug-screening-identifies-small-molecule-inhibitors-of-regulatory-t-cells https://matrix-fkb.no/en/news/esmo-2023-and-summary-of-matrix-relevant-activities https://matrix-fkb.no/en/news/exciting-program-at-the-acta-oncologica-nordic-precision-cancer-medicine-symposium https://matrix-fkb.no/en/news/functional-precision-medicine https://matrix-fkb.no/en/news/guest-lecture-by-professor-ignacio-wistuba-translating-molecular-pathology-of-lung-cancer-to-the-clinical-practice https://matrix-fkb.no/en/news/helse-forde https://matrix-fkb.no/en/news/immunoregulatory-signal-networks-and-tumor-immune-evasion-mechanisms https://matrix-fkb.no/en/news/innovative-palliative-care-for-people-with-cancer https://matrix-fkb.no/en/news/jane2---shaping-the-eu-networks-of-expertise-on-cancer https://matrix-fkb.no/en/news/johnson-johnson-joins-impress-norway https://matrix-fkb.no/en/news/kjetil-tasken-awarded-the-acta-oncologica-award-by-the-swedish-society-of-oncology https://matrix-fkb.no/en/news/kjetil-tasken-is-awarded-the-uio-innovation-prize https://matrix-fkb.no/en/news/matrix-annual-report-2022 https://matrix-fkb.no/en/news/matrix-annual-report-2023 https://matrix-fkb.no/en/news/matrix-annual-report-2024 https://matrix-fkb.no/en/news/matrix-received-128-million-nok https://matrix-fkb.no/en/news/matrix-scientific-advisory-board-established https://matrix-fkb.no/en/news/mypath-matrix https://matrix-fkb.no/en/news/mypath-matrix-co-organisator-of-first-focus-group-workshop-with-14-esmo-designated-centres https://matrix-fkb.no/en/news/nordic-precision-cancer-medicine-symposium https://matrix-fkb.no/en/news/nordic-precision-cancer-medicine-symposium-2025 https://matrix-fkb.no/en/news/official-opening-of-matrix https://matrix-fkb.no/en/news/official-opening-of-the-horizon-eu-cancer-mission-prime-rose-project https://matrix-fkb.no/en/news/oxford-nanopore-and-matrix-collaborate-to-advance-precision-cancer-medicine-research https://matrix-fkb.no/en/news/pcm4eu-personalised-cancer-medicine-for-all-eu-citizens https://matrix-fkb.no/en/news/pioneering-palliative-care https://matrix-fkb.no/en/news/prime-rose-a-european-precision-cancer-medicine-trial-network-and-implementation-initiative-funded-by-the-eu-cancer-mission https://matrix-fkb.no/en/news/publication-in-nature-reviews-drug-discovery https://matrix-fkb.no/en/news/sigrid-skanland-awarded-researcher-of-the-year-2023 https://matrix-fkb.no/en/news/the-cll-outcome-project-receives-funding-from-european-partnership-for-personalised-medicine https://matrix-fkb.no/en/news/the-institute-for-cancer-research-marked-its-70th-anniversary-during-the-norwegian-cancer-symposium-2024 https://matrix-fkb.no/en/news/the-matrix-rare-project-receives-9-million-nok-for-personalised-treatment-of-patients-with-rare-cancer-types https://matrix-fkb.no/en/news/the-norwegian-cancer-symposium-2024 https://matrix-fkb.no/en/news/the-pharmaceutical-company-beone-medicines-joins-the-clinical-trial-matrix-rare https://matrix-fkb.no/en/news/two-matrix-projects-receive-funding-from-the-norwegian-cancer-society https://matrix-fkb.no/en/news/upcoming-acta-oncologica-nordic-precision-cancer-medicine-symposium-2025 https://matrix-fkb.no/en/pcm4eu-news/academy-for-precision-medicine-in-oncology-save-the-date https://matrix-fkb.no/en/pcm4eu-news/check-out-the-short-promotional-video-introducing-precision-cancer-medicine-and-the-eu-funded-initiative-pcm4eu https://matrix-fkb.no/en/pcm4eu-news/comprehensive-assessment-of-the-existing-landscape-of-personalized-cancer-medicine-in-the-european-union-published-in-esmo-open https://matrix-fkb.no/en/pcm4eu-news/editorial-on-the-european-initiatives-pcm4eu-and-prime-rose-published-in-healthcaretech-outlook https://matrix-fkb.no/en/pcm4eu-news/guidance-on-personalised-diagnostics-published https://matrix-fkb.no/en/pcm4eu-news/large-european-grant-to-make-personalised-cancer-treatment-widely-available https://matrix-fkb.no/en/pcm4eu-news/pcm4eu-at-the-molecular-analysis-for-precision-oncology-congress-2023 https://matrix-fkb.no/en/pcm4eu-news/pcm4eu-consortium-meeting-and-spring-academy-in-porto https://matrix-fkb.no/en/pcm4eu-news/pcm4eu-consortium-meets-in-leiden-for-final-conference https://matrix-fkb.no/en/pcm4eu-news/pcm4eu-podcast-series-about-cross-border-access-to-clinical-trials https://matrix-fkb.no/en/pcm4eu-news/pcm4eu-project-meeting-in-oslo https://matrix-fkb.no/en/pcm4eu-news/pcm4eu-successfully-kicks-off-in-leiden https://matrix-fkb.no/en/pcm4eu-news/pcm4eu-workshop-at-the-nordic-precision-medicine-forum-in-stockholm-28-april-2025 https://matrix-fkb.no/en/pcm4eu-news/report-pcm4eu-mpne-april-28-2023 https://matrix-fkb.no/en/pcm4eu-news/the-first-pcm4eu-podcast-episodes-are-now-available https://matrix-fkb.no/en/pcm4eu-news/the-pcm4eu-spring-academy-for-precision-medicine-in-oncology https://matrix-fkb.no/en/pcm4eu-news/upcoming-course-advantages-and-limitations-of-precision-oncology-in-clinical-practice https://matrix-fkb.no/en/pcm4eu-news/upcoming-pcm4eu-event-in-oslo https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/cancer-research-uk-cruk https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/capital-region https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/center-for-innovation-in-medicine-inomed https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/centre-leon-berard https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/centrul-de-oncologie-sf-nectarie https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/heidelberg-university-hospital https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/helsinki-university-hospital-hus https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/ipo-porto https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/istituto-europeo-di-oncologia https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/karolinska-institutet https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/leiden-university-medical-center-lumc https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/maria-sklodowska-curie-institute-of-oncology https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/masaryk-memorial-cancer-institute-mmci https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/national-cancer-institute-nvi https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/national-institute-of-oncology-nio https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/oslo-university-hospital https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/radboud-university-medical-center https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/region-skane https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/region-uppsala https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/sahlgrenska-university-hospital https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/stockholm-school-of-economics-institute-for-research-sir https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/swedish-institute-for-health-econimics-ihe https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/tartu-university-hospital-tuh https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/the-netherlands-cancer-institute-nki https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/trinity-college-dublin https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/university-hospital-of-split-kbc-split https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/university-of-manchester https://matrix-fkb.no/prime-rose-beneficiaries-associated-partners/vall-dhebron-institute-of-oncology-vhio https://matrix-fkb.no/prime-rose-news/accelerating-precision-oncology-prime-rose-unites-drup-like-clinical-trials-across-europe https://matrix-fkb.no/prime-rose-news/editorial-on-the-european-initiatives-pcm4eu-and-prime-rose-published-in-healthcaretech-outlook https://matrix-fkb.no/prime-rose-news/esmo-2023-and-prime-rose-activities-in-madrid https://matrix-fkb.no/prime-rose-news/first-drup-like-clinical-trials-community-advisory-board-in-prime-rose---health-related-quality-of-life https://matrix-fkb.no/prime-rose-news/new-swedish-clinical-study-expands-access-to-precision-cancer-medicine https://matrix-fkb.no/prime-rose-news/official-opening-of-the-horizon-eu-cancer-mission-prime-rose-project https://matrix-fkb.no/prime-rose-news/prime-rose-activities-at-the-esmo-2024-congress-in-barcelona https://matrix-fkb.no/prime-rose-news/prime-rose-activities-during-the-esmo-2024-congress-in-barcelona https://matrix-fkb.no/prime-rose-news/prime-rose-advances-precision-cancer-medicine-with-groundbreaking-data-collaboration https://matrix-fkb.no/prime-rose-news/prime-rose-at-esmo-2025-showcasing-precision-cancer-medicine-across-europe https://matrix-fkb.no/prime-rose-news/prime-rose-at-esmo-2025-strengthening-collaboration-in-precision-cancer-medicine https://matrix-fkb.no/prime-rose-news/prime-rose-at-map2025-esmo2025-driving-precision-oncology-forward https://matrix-fkb.no/prime-rose-news/prime-rose-eu-project-receives-6-million-eur-from-eu-cancer-mission https://matrix-fkb.no/prime-rose-news/prime-rose-is-present-at-the-esmo-2023-congress https://matrix-fkb.no/prime-rose-news/prime-rose-kick-off-event-19-20-september https://matrix-fkb.no/prime-rose-news/prime-rose-unlocking-the-power-of-connectivity-advancing-data-sharing https://matrix-fkb.no/prime-rose-news/prime-rose-updates-on-cohort-merging-and-biomarker-alignment https://matrix-fkb.no/pcm4eu-academy/spring-academy-in-porto-educating-the-next-generation-of-leaders-in-personalized-cancer-medicine